PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL)
Clinical trials for PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL) explained in plain language.
Never miss a new study
Get alerted when new PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL) trials appear
Sign up with your email to follow new studies for PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail of smart drugs aims to wipe out leukemia with less poison
Disease control Not yet recruitingThis phase 2 trial tests a new approach for adults newly diagnosed with a type of leukemia called Ph-negative B-ALL. Instead of standard high-dose chemo, patients get a mix of low-dose chemo plus several targeted drugs (Inotuzumab, Venetoclax, Blinatumomab) and possibly CAR-T cel…
Matched conditions: PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New drug combo aims to stop leukemia from coming back after transplant
Disease control Not yet recruitingThis study tests whether adding asciminib to standard therapy after a stem cell transplant can help prevent leukemia from returning in people with certain types of blood cancer (Ph+ B-ALL or blastic phase CML). About 45 adults will be randomly assigned to receive either the stand…
Matched conditions: PH- ACUTE LYMPHOBLASTIC LEUKEMIA (PH-ALL)
Phase: PHASE2 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC